sevoflurane has been researched along with Depression in 4 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sevoflurane anesthesia impaired cognitive functions, as well as metabotropic glutamate receptor-dependent long-term depression, through elevated surface expression of small conductance calcium-activated potassium type 2 channels." | 7.91 | Sevoflurane anesthesia impairs metabotropic glutamate receptor-dependent long-term depression and cognitive functions in senile mice. ( Shi, J; Yu, X; Zhang, F, 2019) |
| "Sevoflurane anesthesia impaired cognitive functions, as well as metabotropic glutamate receptor-dependent long-term depression, through elevated surface expression of small conductance calcium-activated potassium type 2 channels." | 3.91 | Sevoflurane anesthesia impairs metabotropic glutamate receptor-dependent long-term depression and cognitive functions in senile mice. ( Shi, J; Yu, X; Zhang, F, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, M | 1 |
| Cheng, S | 1 |
| Fang, Y | 1 |
| Lv, L | 1 |
| Guo, P | 1 |
| Wang, S | 1 |
| Chen, H | 1 |
| Yu, X | 1 |
| Zhang, F | 1 |
| Shi, J | 1 |
| Zhang, H | 1 |
| Li, L | 1 |
| Sun, Y | 1 |
| Zhang, X | 1 |
| Zhang, Y | 1 |
| Xu, S | 1 |
| Zhao, P | 1 |
| Liu, T | 1 |
| Iohom, G | 1 |
| Szarvas, S | 1 |
| Larney, V | 1 |
| O'Brien, J | 1 |
| Buckley, E | 1 |
| Butler, M | 1 |
| Shorten, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Subanesthetic Sevoflurane for Treatment-Resistant Depression: A Proof-of-Concept Trial[NCT05008939] | 15 participants (Anticipated) | Interventional | 2021-08-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for sevoflurane and Depression
| Article | Year |
|---|---|
Perioperative plasma concentrations of stable nitric oxide products are predictive of cognitive dysfunction after laparoscopic cholecystectomy.
Topics: Adult; Affect; Aged; Aged, 80 and over; Algorithms; Anesthesia, Inhalation; Anesthetics, Inhalation; | 2004 |
3 other studies available for sevoflurane and Depression
| Article | Year |
|---|---|
Augmentation of Sevoflurane inhalation for treatment-resistant depression with different features: A case series.
Topics: Antidepressive Agents; Antipsychotic Agents; Depression; Depressive Disorder, Treatment-Resistant; D | 2023 |
Sevoflurane anesthesia impairs metabotropic glutamate receptor-dependent long-term depression and cognitive functions in senile mice.
Topics: Aging; Anesthesia; Anesthetics, Inhalation; Animals; Cognition; Cognitive Dysfunction; Depression; E | 2019 |
Sevoflurane prevents stroke-induced depressive and anxiety behaviors by promoting cannabinoid receptor subtype I-dependent interaction between β-arrestin 2 and extracellular signal-regulated kinases 1/2 in the rat hippocampus.
Topics: Anesthetics, Inhalation; Animals; Anxiety; beta-Arrestin 2; Depression; Dose-Response Relationship, | 2016 |